Conformationally constrained spirocycles (17-23) and (31-36) were synthesised. In vitro data revealed that these compounds are CCR1 antagonists with sub-nanomolar potency. In a functional assay 22, 23 and 36 inhibited CCR1 mediated chemotaxis with an IC50 value of 2, 2.6 and 68nM, respectively.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmcl.2012.12.095 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!